Germ Cell Tumours: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 785: | Line 785: | ||
*# '''<span style="color:#ff0000">Adjuvant primary chemotherapy (BEPx1-2)</span>''' | *# '''<span style="color:#ff0000">Adjuvant primary chemotherapy (BEPx1-2)</span>''' | ||
*#* '''Newer guidelines, such as 2019 AUA guidelines, recommend 1 cycle for CSIA and 2 cycles for CSIB''' | *#* '''Newer guidelines, such as 2019 AUA guidelines, recommend 1 cycle for CSIA and 2 cycles for CSIB''' | ||
* | *#* '''2010 CUA Consensus Statement: BEPx2''' | ||
** Long-term survival approaches 100% for each | ** Long-term survival approaches 100% for each | ||
** '''Guidelines''': | ** '''Guidelines''': | ||